KIMRON VETERINARY INSTITUTE

Their core work

Kimron Veterinary Institute is Israel's national veterinary research laboratory, responsible for diagnosing and studying animal diseases of economic and public health significance. In EU research, they contribute field epidemiology, diagnostic expertise, and disease surveillance for transboundary livestock pathogens — primarily viruses that spread across borders via insect vectors or animal movements. Their H2020 work covers both vector-borne diseases (bluetongue transmitted by Culicoides midges) and highly contagious viral threats to European and Middle Eastern livestock herds (African Swine Fever and Lumpy Skin Disease). As a national institute with continuous surveillance infrastructure, they bring real-world monitoring data that academic partners typically cannot provide.

What they specialise in

How they've shifted over time

Their early H2020 work (PALE-Blu, starting 2017) was tightly focused on a single vector-borne disease — bluetongue — with an ecological lens examining how the pathogen, its Culicoides insect vector, and livestock populations interact. By 2018 they had moved into DEFEND, which spans two entirely different pathogens (African Swine Fever and Lumpy Skin Disease) and adds a vaccine development and multi-actor policy dimension. This shift suggests a deliberate broadening from specialist vector-disease ecology toward a wider portfolio of economically devastating emerging livestock disease threats — likely driven by the real-world spread of ASF and LSD into Europe during this period.

Kimron is evolving from a single-disease vector specialist into a broader emerging animal disease partner — an organization to consider for any consortium tackling new or re-emerging livestock pathogens threatening European borders.

How they like to work

Kimron participates exclusively as a consortium member rather than a project coordinator, suggesting they contribute well-defined specialist expertise within larger coordinated programs rather than driving project agendas. Both projects are large RIA consortia, and their network of 49 unique partners from 26 countries — reached through just two projects — indicates integration into major pan-European disease networks with broad institutional diversity. This points to an organisation that is a reliable, sought-after specialist contributor rather than a broad research generalist.

With 49 unique consortium partners across 26 countries from only two projects, Kimron is embedded in large, geographically diverse disease surveillance networks. As an Israeli institute operating outside the EU, they provide a strategically valuable link between European livestock disease management programs and the Mediterranean and Middle Eastern corridors through which many vector-borne and transboundary pathogens travel.

What sets them apart

As Israel's national veterinary institute, Kimron occupies a geographic position that is genuinely rare in EU consortia — Israel sits on migratory flyways and vector dispersal routes connecting sub-Saharan Africa, the Middle East, and the Balkans, making it a natural early-warning sentinel for pathogens moving toward Europe. This gives their epidemiological data a predictive value for European disease forecasting that no EU-based partner can replicate. Their national mandate also means they maintain continuous, standardised diagnostic and surveillance infrastructure year-round, not just for the duration of a funded project.

Highlights from their portfolio

• PALE-Blu
  Kimron's only funded project (EUR 87,500) and their entry into EU research networks — a multi-country ecological study of bluetongue that positioned them as a specialist in insect-vector disease dynamics.
• DEFEND
  A high-priority dual-pathogen project addressing African Swine Fever and Lumpy Skin Disease simultaneously — two of the most economically damaging livestock disease threats to reach Europe in decades, giving Kimron exposure to EU policy-level biosecurity work.